Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Patient Perspectives - Clinical Trials Experiences through Storytelling Participants for 2025
dbrock
We are pleased to introduce three amazing participants working with GRACE to produce educational content by telling their clinical trials stories!
Image
GRACE is pleased to introduce three amazing individuals participating in the 2024-25 GRACE Clinical Trials Experiences Storytelling Program
We are thrilled to introduce this year’s participants in the Clinical Trials Storytelling Program! Representing diverse cancer types and a range of clinical trial experiences, these incredible individuals will collaborate with GRACE to create meaningful content across multiple platforms. Through their stories, they will become established contributors, sharing their personal journeys in powerful, educational ways. We are eager to share these powerful stories and provide support to others navigating similar paths.
Image
Virginia (Ginny) Haessly
Ginny was diagnosed with Melanoma in 2017 and became a participant in the SWOG 1404 clinical trial. Her incredible story continues to this day. She is interested in helping to advance Survivorship Care after having received immunotherapy, and continues to learn more about her continued care needs. She is a retired Retail Buyer, a wife, a mom and dog mom, and a sailor.
Image
Catherine Wambugu
Catherine lives in Nairobi, Kenya, and is a champion, a childhood cancer advocate, and a mentor dedicated to supporting kids, teens, and young adults battling cancer. As the founder of Hope & Courage International, Catherine works to create safe spaces, provide essential resources, and amplify the voices of young cancer warriors. Her passion stems from personal experience, and she strives to bring hope and resilience to those facing life’s toughest battles.
Image
Mike Herman
Mike Herman is a passionate cancer patient advocate, 11-year survivor of an incurable cancer, and Founder of Speaking on Cancer Patient Advocacy. As the driving force behind the High School C.A.R.E.s initiative, he is dedicated to educating the next generation on cancer prevention, early detection, and the power of advocacy. Featured in Cancer Today and a sought-after speaker, Mike collaborates with leading organizations like ACS, AACR, and NCI to push for a cancer-free future.
https://www.linkedin.com/in/freelance-writer-health-cancer-pharma-healthtech-content/
Many thanks to our sponsors for this important program this year! #exelixis #lilly
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Video
In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their stories in order to help others who may be navigating the clinical trials experience.
In this 2nd series of videos, Michael Herman takes us through the story of his diagnosis, his struggles with treatment options, his clinical trial and his learning curve.
Thank you to our Sponsors! #lilly #exelixis
Article
Head and neck cancers linked to human papillomavirus (HPV) are very different from those caused by tobacco or alcohol. The good news is that HPV-positive cancers usually respond better to treatment and often have better outcomes.
Image
Video
In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their stories in order to help others who may be navigating the clinical trials experience.
Online Community
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...
The prefix “oligo–” means few. Oligometastatic (at diagnosis) Oligoprogression (during treatment)
There will be a discussion, “Studies in Oligometastatic NSCLC: Current Data and Definitions,” which will focus on what we...
Radiation therapy is primarily a localized treatment, meaning it precisely targets a specific tumor or area of the body, unlike systemic treatments (like chemotherapy) that affect the whole body.
The...
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.